The Valley Desk

Clinical trial reportThe European respiratory journalPublished

Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University. Affiliation source

Publication record

Type
Clinical trial report
Venue
The European respiratory journal
Published
Subject terms
Humans; Sarcoidosis, Pulmonary; Chronic Disease; Adrenal Cortex Hormones; Granulocyte-Macrophage Colony-Stimulating Factor; Immunosuppressive Agents; Treatment Outcome; Double-Blind Method; Adult; Aged; Middle Aged; Female
PubMed ID
41819539
PubMed Central ID
PMC13347716
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal